Sichuan SRK Biotechnology Co., Ltd. (hereinafter referred to as "SRK") is a research and technology talent team supported by East China University of Science and Technology and Sichuan Traditional Chinese Medicine System Engineering Research Institute. It is LED by Hong Kong Baixin International Holdings Group with a total investment of 3 billion. Hong Kong dollar, specializing in the industrialization of fully degradable biomaterial polylactic acid (PLA). The project was introduced by the Sichuan Economic Cooperation Bureau and has been listed as a major project in Chengdu. It has been settled in the Wenjiang Chengdu Cross-Strait Science and Technology Industrial Park.

Hong Kong Baixin International Holdings Group is a Hong Kong stock listed company specializing in the production and sale of pharmaceuticals (code: 00574). It established its international headquarters in Hong Kong in 1979 and is now relocating to Toronto, Canada. The domestic headquarters is located in Wuhan. Under the guidance of the business policy of "rooting the mainland, radiating Asia, facing the world", after nearly 30 years of hard work, it has developed into a diversified and comprehensive multinational group with a wide reputation in North America, Eastern Europe and Southeast Asia.

The SRK production base is located in the Strait Science and Technology Industry Development Park of Wenjiang District, Chengdu, only 20 kilometers away from Chengdu City. The transportation is convenient. The factory has beautiful environment, fresh air, no pollution source, low atmospheric dust and good natural environment. At the same time, the Wenjiang District Government provided Serik with nearly 2, 000 flat office space in the hot spring section, which provided great convenience for Syrac to attract talents and accelerate the transformation of results.

PLA is a kind of bio-sourced, non-petroleum-based environmentally friendly material with good biodegradability and biocompatibility. It is the best choice for solving the "oil crisis" and "white pollution". Fracture fixation materials, tissue engineering stents and other fields such as medical, agroforestry, food packaging, etc.

SRK will adhere to the principles of innovation and pragmatism. Actively explore the issues of global human health from the source, and strive to create a green and healthy life and create brilliance. (Including detailed company introductions, such as history, performance, business scope, development prospects, etc. )